Characteristics of Primary Care Providers' Consultations With a Statewide Child Psychiatry Access Program Regarding Autism Spectrum Disorder
JournalJournal of the Academy of Consultation-Liaison Psychiatry
MetadataShow full item record
AbstractBackground: Child Psychiatry Access Programs (CPAPs) provide consultative support for pediatric primary care providers (PCPs) to treat co-morbid mental health (MH) symptoms among patients with Autism Spectrum Disorder (ASD). Objectives: We examined differences in illness severity, comorbidity, and psychotropic medication use between patients with and without ASD for whom primary care providers sought consultation from Maryland's CPAP. Methods: We examined N = 3641 Maryland's CPAP consultations from 2012 to 2019; n = 311 were consultations for ASD. Demographics, treatment recommendations, diagnoses, and Clinical Global Impression-Severity scores were collected. Patients who received psychotropic medication or psychotherapy by an mental health provider were defined as comanaged. Descriptives and logistic regression were conducted. Sample size for regression was N = 1854. Results: Compared with non-ASD, patients with consults for ASD were more often male (P < 0.001), aged 0–5 years (P < 0.001), severely ill (Clinical Global Impression-Severity > 4) (P < 0.001), and prescribed stimulants, nonstimulant attention-deficit hyperactivity disorder medications, and antipsychotics (P < 0.001). Controlling for key covariates, consultations for youth displaying aggression were 3.02 times (P < 0.001) more likely, with Clinical Global Impression-Severity > 4 were 2.36 times (P < 0.001) more likely, and prescribed antipsychotics were 4.30 times more likely to concern an ASD patient (P < 0.001). A larger proportion of ASD patients (vs. non-ASD) had comorbid psychiatric diagnoses of attention-deficit hyperactivity disorder, a learning disability, and disruptive behavior disorder vs. a smaller proportion with major depressive disorder. Conclusions: ASD patients for whom primary care providers sought Maryland's CPAP consultation were more severe and complex than non-ASD patients in terms of comorbid diagnoses and medication regimen. Findings suggest that consultations with CPAPs provide medication management support to pediatric primary care providers treating ASD patients. © 2022 The Authors
SponsorsU.S. Department of Health and Human Services
Keywordautism spectrum disorder
child psychiatry access program
collaborative mental health care
pediatric mental health care
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18569
- Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
- Authors: Yamamuro K, Tsujii N, Ota T, Kishimoto T, Iida J
- Issue date: 2017 Aug
- Characteristics of Providers Using a Child Psychiatry Access Program.
- Authors: Cotton A, Riddle MA, Reinblatt SP, Bettencourt AF
- Issue date: 2021 Oct 1
- Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
- Authors: Houghton R, Liu C, Bolognani F
- Issue date: 2018 Dec
- Severity of mental health concerns in pediatric primary care and the role of child psychiatry access programs.
- Authors: Platt R, Pustilnik S, Connors E, Gloff N, Bower K
- Issue date: 2018 Jul - Aug
- Multiple Antipsychotic Medication Use in Autism Spectrum Disorder.
- Authors: Wink LK, Pedapati EV, Horn PS, McDougle CJ, Erickson CA
- Issue date: 2017 Feb